Black Hawk Acquisition Corp

BKHAR

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0002000775

SEC filings (opens in a new tab)

No open-market purchases or sales by Black Hawk Acquisition Corp insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.46M in total; no superinvestor holds it.

Other share classesBKHA BKHAU

Superinvestors holding BKHAR, Q2 2026

See all superinvestors

No superinvestor reported holding BKHAR in Q2 2026.